Dr. Paul Mathew

Paul George Mathew, M.D.

Harvard Title

Assistant Professor of Neurology

Other Affiliations

Mass General Brigham

Atrius Health

Cambridge Health Alliance

Address

Mass General Brigham

Department of Neurology

20 Patriot Place

Foxboro MA 02035

Publications View
Preliminary results of a randomized placebo-controlled double-blind trial of weekly docetaxel combined with imatinib in men with metastatic androgen-independent prostate cancer (AIPC) and bone metastases (BM).
Authors: Mathew P, Thall PF, Johnson MM, Oh WK, Meluch AA, Morris MJ, Troncoso P, Bucana CD, Fidler IJ, Logothetis CJ.
J Clin Oncol
View full abstract on Pubmed
Phase II study of capecitabine combined with gemcitabine in the treatment of androgen-independent prostate cancer previously treated with taxanes.
Authors: Rodney A, Dieringer P, Mathew P, Jonasch E, Tannir N, Pagliaro LC.
Cancer
View full abstract on Pubmed
Platelet-derived growth factor receptor inhibitor imatinib mesylate and docetaxel: a modular phase I trial in androgen-independent prostate cancer.
Authors: Mathew P, Thall PF, Jones D, Perez C, Bucana C, Troncoso P, Kim SJ, Fidler IJ, Logothetis C.
J Clin Oncol
View full abstract on Pubmed
Combination docetaxel and platelet-derived growth factor receptor inhibition with imatinib mesylate in prostate cancer.
Authors: Mathew P, Fidler IJ, Logothetis CJ.
Semin Oncol
View full abstract on Pubmed